Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20020077593 A1
Publication typeApplication
Application numberUS 10/074,861
Publication date20 Jun 2002
Filing date11 Feb 2002
Priority date21 Oct 1999
Also published asUS6398775, WO2003105941A1
Publication number074861, 10074861, US 2002/0077593 A1, US 2002/077593 A1, US 20020077593 A1, US 20020077593A1, US 2002077593 A1, US 2002077593A1, US-A1-20020077593, US-A1-2002077593, US2002/0077593A1, US2002/077593A1, US20020077593 A1, US20020077593A1, US2002077593 A1, US2002077593A1
InventorsRodney Perkins, Peter Soltesz, Robert Kotmel
Original AssigneePulmonx
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Apparatus and method for isolated lung access
US 20020077593 A1
Abstract
Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.
Images(16)
Previous page
Next page
Claims(17)
What is claimed is:
1. An isolation catheter comprising:
a catheter body having a proximal end, a distal end, and a main lumen therethrough;
an expansible occlusion member disposed on the catheter body near the distal end thereof;
optical and illumination fibers disposed in the catheter body to image a region distal to the distal end of the catheter body; and
a hub attached to the proximal end of the catheter body, said hub having a connector port for at least the main lumen.
2. An isolation catheter as in claim 1, wherein the catheter body has a length in the range from 20 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm and the main lumen has a diameter from 1 mm to 6 mm.
3. An isolation catheter as in either claim 1 or 2, wherein the expansible occlusion member is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm and a length in the range from 5 mm to 30 mm.
4. An isolation catheter as in claim 3, wherein the catheter body further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff and wherein the hub has an additional connector port for the inflation lumen.
5. An isolation catheter as in either claim 1 or 2, wherein the catheter body further comprises a lumen disposed to direct a washing fluid over a distal tip of the optical fiber.
6. An isolation lung infusion/aspiration system, said system comprising:
an isolation catheter according to either of claims 1 and 2; and
an inner catheter having a proximal end, a distal end, and a central lumen therethrough, said inner catheter being positionable within the main lumen of the sub-lobar isolation catheter to form an annular lumen within the main lumen.
7. A system as in claim 6, wherein the hub has an additional connector port for the annular lumen.
8. A system as in claim 6, further comprising an adaptor connectable to the hub, wherein the adaptor has a connector port for the annular lumen.
9. A system as in claim 6, wherein the inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, an inner diameter in the range from 0.1 mm to 3.5 mm, and a length at least 10 cm longer than the isolation catheter.
10. A system as in claim 9, wherein the inner catheter has a length in the range from 50 cm to 200 cm.
11. A system as in claim 6, wherein the inner catheter has an expansible occlusion member disposed near its distal end.
12. A system as in claim 11, wherein the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, and a length in the range from 5 mm to 30 mm.
13. A system as in claim 11, wherein the inner catheter further comprises an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff on the inner catheter.
14. A system as in claim 6, wherein the inner catheter further comprises an infusion/aspiration lumen having at least one distal port positioned proximally of the inflatable cuff on the inner catheter.
15. A system as in claim 6, wherein the inner catheter further comprises a vibratory element near the distal end thereof.
16. A system as in claim 6, wherein the inner catheter comprises at least two lumens which are joined near a distal end of the inner catheter and which have a common outlet port.
17. An isolation catheter as in claim 1 or 2, further comprising a vibratory element near the distal end thereof.
Description
    CROSS-REFERENCES TO RELATED APPLICATIONS
  • [0001]
    This application is a division of application Ser. No. 09/425,272, filed on Oct. 21, 1998, now U.S. Pat. No. ______, the full disclosure of which is incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • [0002]
    1. Field of the Invention
  • [0003]
    The present invention relates generally to medical apparatus, systems, methods, and kits. More particularly, the present invention relates to methods and apparatus for isolating sub-bronchial regions of the lung and delivering or retrieving substances from such isolated regions.
  • [0004]
    Lung access and isolation is of interest in numerous therapeutic and diagnostic medical procedures. In particular, access to the lungs is useful for both local and systemic drug delivery, lung lavage, visual assessment and diagnosis of lung function, and the like.
  • [0005]
    For drug delivery, access is most simply achieved by introducing an aerosol to the lungs through the mouth or nose, and a variety of inhalers, nebulizers, metered dose inhalers (MDIs), nasal sprayers, and the like, have been developed over the years. While very effective for many drugs, delivery through the mouth or nose can be very inefficient, often with less than 20% of the drug reaching circulation or a targeted local treatment region. Moreover, inhalation through the mouth or nose is not able to target drug delivery to a particular region of the lungs. While this may not be a problem for systemic delivery, it can be a significant drawback in the treatment of localized disease where a highly controlled delivery profile would be preferred.
  • [0006]
    In an effort to overcome at least some of these shortcomings, a variety of endotracheal drug delivery and lung lavage systems have been developed. Most simply, an endotracheal or tracheostomy tube having an inflatable cuff at its distal end may be placed in a patient's trachea and used to deliver a drug aerosol to the whole of the lungs. While this can improve the efficiency of drug delivery (reducing the amount of drug deposited in the nasal passages or throat), it helps little in targeting treatment within any particular region of the lungs. Thus, it has been further proposed to use a secondary catheter placed through an endotracheal or tracheostomy tube for selectively isolating the left or right bronchus. For example, the secondary catheter can have an inflatable cuff which is positioned immediately beyond the main branching between the left and right bronchi. One of the bronchi can then be accessed through the secondary catheter while the other is accessed through the tracheal tube. Such systems are described, for example, in U.S. Pat. Nos. 5,285,778 and 5,660,175. While such systems offer significant benefits over the use of an endotracheal tube by itself, they still do not permit isolation of sub-bronchial regions of the lung for drug delivery, lavage, or any other purpose.
  • [0007]
    A system for bronchoalveolar lavage which can isolate a sub-bronchial region of the lung is described in published Application No. WO 92/10971. A co-axial catheter system is placed through an endotracheal tube, with the inner most catheter having an isolation wedge or balloon which can be positioned in a remote bronchiole to effect isolation of a distal region of the lung. The outer catheter has no capability for isolating the lung and is used, for example, for ventilating the lung proximal to the isolation cuff. While potentially an improvement over prior systems, the apparatus of WO 92/10971 will be very difficult to position, making targeting of particular sub-bronchial regions very difficult. Moreover, the inability to isolate a bronchus upstream from the distal isolation cuff limits the ability to selectively treat different regions of the bronchus in different ways. That is, while the particular sub-bronchial region which is isolated by the distal isolation cuff may be treated in one way, the remainder of that bronchus as well as the entire other lung must be ventilated and treated in a common manner through either the endotracheal tube or the outer catheter of the co-axial catheter pair.
  • [0008]
    For these reasons, it would be desirable to provide improved apparatus, systems, methods, and kits for the treatment and diagnosis of selected regions of a patient's lungs, particularly a lobar or targeted sub-lobar regions of the patient's lungs. The present invention should provide for the efficient delivery of pharmaceutical and other substances to the targeted sub-lobar regions of the lung. Moreover, in some embodiments, the present invention should be able to provide at least a second level of isolation within a particular bronchus and/or the ability to instill the pharmaceuticals or other substances at a point significantly distal to a point of isolation within the bronchus. The systems and apparatus of the present invention should be capable of being positioned precisely to a targeted bronchi within the bronchus, preferably providing on-board visualization while components of the system are positioned over a guidewire. Additionally, the apparatus, systems, methods, and kits of the present invention should be suitable for a wide variety of purposes, including pharmaceutical drug delivery, lung lavage (optionally in combination with drug delivery), diagnosis (optionally in combination with lung lavage), and the like. In particular, the present invention should be useful for localized drug delivery where a particular drug or other therapeutic agent can be delivered to a well-defined, isolated sub-bronchial region of the lung (as defined hereinafter) with little or no delivery to other regions of the lung. At least some of these objectives will be met by the inventions described hereinafter.
  • [0009]
    2. Description of the Background Art
  • [0010]
    WO 92/10971 describes a bronchoalveolar lavage catheter system having an outer catheter and an inner catheter with an enlarged (optionally inflatable) tip which is advanced until the tip wedges in a bronchiole of the patient. A region of the lungs distal to the enlarged tip may then be lavaged to retrieve sample. U.S. Pat. Nos. 5,660,175; 5,653,231; 4,716,896; and 4,453,545, describe single and co-axial catheter systems for accessing a patient's lungs. U.S. Pat. No. 5,285,778, describes a co-axial endoscopic lung access system. U.S. Pat. Nos. 5,309,903 and 5,207,220 describe systems for administering liquid pharmaceutical formulations to an isolated lung.
  • BRIEF SUMMARY OF THE INVENTION
  • [0011]
    The present invention provides improved apparatus, systems, methods, and kits for isolating lobar and sub-lobar regions of a patient's lungs. The isolated region will be a portion (not the whole) of the right or left lung, and isolation will be accomplished by occluding a bronchial passage at at least one location in the lobar, segmental, and subsegmental bronchus. Thus, a primary occlusion will be formed after both the main bifurcation of the trachea and a further bifurcation into the lobar bronchus. Optionally, the lobar and/or sub-lobar region can be further isolated at at least one secondary location distal to the primary point of isolation and usually after further branching of the bronchial passages. Isolation at the primary location and optional additional locations within the bronchial passages will usually be effected by expansion of an occlusion member, such as an inflatable cuff, inflatable balloon, or the like.
  • [0012]
    Once the lobar or sub-lobar region has been isolated, a variety of therapeutic and diagnostic procedures can be performed within the isolated region. For example, pharmaceutical formulations including small molecule drugs, biological macromolecular drugs, and the like, can be specifically delivered to the isolated region with minimal or no cross-delivery to other regions of the lungs. Similarly, lavage may be performed within the isolated region with minimal impact on adjacent regions of the lungs. Isolation of the lobar or sub-lobar region permits such drug delivery and lavage procedures to be further controlled by control of the volumes, rates, pressures, temperatures, repetitions, retention times, and other method and system parameters. For example, the pressure within the isolated region can be controlled separately from the pressure or pressures maintained outside of the isolated region. In this way, a variety of delivery parameters can be controlled. By elevating pressure within the isolated region above that in the surrounding regions of the lung, the isolated lobar or sub-lobar region will be expanded which may, in some cases, enhance delivery of a drug or permit more efficient lavage of the region. Alternatively, by elevating pressure within the “other” lung regions above that within the isolated region, the risk of migration of toxic therapeutic or other agents away from the isolated region can be greatly reduced.
  • [0013]
    According to the present invention, an isolation catheter comprises a catheter body having a proximal end, a distal end, and a main lumen therebetween. An expansible occlusion member is disposed at or near the distal end of the catheter body, and optical and illumination fibers are disposed in the catheter body to permit imaging of a region distal to the distal end of the catheter body when the catheter is in use. Usually, a hub will be attached to the proximal end of the catheter and include at least one connection port for the main lumen of the catheter. Optionally, the hub will contain a second connection port for the optical and illumination fibers, and may contain further connection ports for other lumens and capabilities of the catheter, as described hereinafter.
  • [0014]
    The catheter body of the isolation catheter will be adapted and sized to allow advancement of the distal end of the catheter body to a target bronchial passage within the lung which is located distal to a first branching of the right or left main stem bronchus. Usually, at least a distal region of the catheter body will have an outer diameter which is sufficiently small and flexible to be advanced into bronchioles having a diameter below about 12 mm, preferably below about 10 mm, and often below about 8 mm. Exemplary catheter bodies will have a length in the range from 40 cm to 150 cm, preferably from 50 cm to 90 cm, an outer diameter in the range from 2 mm to 7 mm, preferably from 3 mm to 6 mm, and a main lumen diameter in the range from 1 mm to 6 mm, preferably from 2 mm to 4 mm. The expansible occlusion member will typically be an inflatable cuff or balloon having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm. Usually, the catheter body will include at least one additional lumen for inflation of the inflatable cuff, and the additional lumen will be connected to an additional connector port on the catheter hub. Further optionally, the catheter body may include an additional lumen disposed to direct a washing fluid over a distal tip of the optical fiber which terminates at or near the distal end of the catheter body.
  • [0015]
    In a preferred aspect, systems according to the present invention comprises an isolation catheter as described above combined with an inner catheter to form a lung infusion/aspiration system. The inner catheter has a proximal end, a distal end, and a central lumen extending between the proximal end and distal end. The inner catheter is positionable within the main lumen of the isolation catheter so that the catheters may be used together in a co-axial fashion and further so that an annular lumen is formed within the main lumen of the isolation catheter, i.e., between an inner surface of the main lumen of the isolation catheter and an outer surface of the inner catheter. Optionally, the connector port on the isolation catheter has an additional connector port for the annular lumen. Alternatively, the system may comprise an adapter connectable to the hub on the isolation catheter, where the adapter has a connector port for the annular lumen. The dimensions and physical characteristics of the inner catheter will be chosen to permit introduction through the main lumen of the isolation catheter and further to permit advancement of the inner catheter beyond the distal end of the isolation catheter into bronchial passages or bronchioles distal to the isolation catheter when in use.
  • [0016]
    An exemplary inner catheter has an outer diameter in the range from 0.5 mm to 4.5 mm, preferably from 1.5 mm to 3.5 mm, an inner lumen diameter in the range from 0.1 mm to 3.5 mm, preferably from 1 mm to 3 mm, and a length which is at least 10 cm longer than the isolation catheter in the system. Typically, the inner catheter will have a length in the range from 50 cm to 200 cm, preferably from 60 cm to 110 cm. Optionally, the inner catheter may have an expansible occlusion member disposed near its distal end to permit selective isolation of a lobar or sub-lobar region between proximal and distal points along the bronchial passages of the lung. Typically, the expansible occlusion member on the inner catheter is an inflatable cuff having an expanded diameter in the range from 4 mm to 18 mm, preferably from 6 mm to 15 mm, and a length in the range from 5 mm to 30 mm, preferably from 10 mm to 15 mm.
  • [0017]
    When including an inflatable cuff, the inner catheter will usually further comprise an inflation lumen disposed to deliver and remove an inflation medium to the inflatable cuff. Moreover, when provided with an inflatable cuff, the inner catheter will usually comprise an infusion/aspiration lumen having a distal port position proximally of the inflatable cuff so that substances, washing fluids, or the like, may be delivered or aspirated through the lumen between the inflatable cuff on the isolation catheter and the inflatable cuff on the inner catheter. Still further optionally, the inner catheter may comprise a vibratory element, such as an ultrasonic transducer, near its distal end to assist in dissolution of occlusive materials, enhance drug uptake, or the like. Still further optionally, the inner catheter may comprise two or more lumens, where at least two of the lumens are joined near a distal end to permit mixing of two or more gas or liquid streams which are being delivered through the catheter. The mixed streams are then released through a common outlet port on the inner catheter. Alternatively, the two streams may be delivered in parallel from the distal tip of the inner catheter for a variety of purposes.
  • [0018]
    The systems of the present invention may comprise further elements, such as guidewires, tracheal tubes with integral visualization (including both endotracheal and tracheostomy tubes), therapeutic or diagnostic reagents, and/or other system components intended to cooperate in performing the methods of the present invention as described in more detail below. Additionally, the systems of the present invention may be incorporated into kits where one or more system components are packaged together with instructions for use setting forth the methods described in more detail below. Such kits will usually further comprise packages for holding the system component(s) together with the instructions for use.
  • [0019]
    Methods according to the present invention comprise using an isolation catheter and an inner catheter (generally as described above) for isolating a lobar or sub-lobar region of the lung and then performing a procedure within the isolated region. In a first instance, the methods are used for delivering a substance, typically a drug or other pharmaceutically active substance, to the isolated region. In a second instance, the methods are used for ravaging the isolated region, i.e., introducing and removing a washing liquid such as isotonic saline, alcohol, mucolytic agents, or the like, to the region. Optionally, the lavage and substance delivery methods can be combined where a drug or other active agent is included in the washing liquid which is being used for lavage. The methods of the present invention comprise positioning a distal end of the isolation catheter within a bronchial passage beyond a first branching within the right or left lung. The inner catheter is then positioned through the main lumen of the isolation catheter so that a distal end of the inner catheter lies in a bronchial passage distally beyond the distal end of the isolation catheter. At least one occlusion element near the distal end of the isolation catheter is expanded within the bronchial passage to isolate a target lobar or sub-lobar region. Thereafter, in the case of drug or other substance delivery, the substance may be delivered through the inner catheter to the isolated region of the lung. In the case of lavage, the washing liquid may be infused through either (or both) of the inner catheter or the isolation catheter and aspirated through the other (or both) of the two catheters. Infusion and aspiration may be performed sequentially or concurrently, or in combinations of both sequential and concurrent infusion and aspiration. Often, it will be preferred to infuse the washing liquid through the inner catheter so that it enters the isolated region generally in a distal portion thereof and diffuses or migrates back toward the isolation catheter where it is collected and removed. In some instances, the washing liquid drug, or other substance may be introduced as a bolus and held or retained within the isolated sub-lobar region for a pre-selected retention time prior to initiating aspiration. In other instances, it may be desirable to continuously both infuse and aspirate the washing liquid drug, or other substance to get a “circulation” of the substance through the isolated lobar or sub-lobar region. Optionally, the washing liquid may comprise a drug or other biologically active substance to perform a therapeutic action while the region is being ravaged.
  • [0020]
    In the case of substance delivery, the substance may comprise any one of a wide variety of pharmaceutical agents, including small molecule drugs, protein drugs, carbohydrate drugs, nucleic acid drugs (genes, optionally in combination with delivery vectors and/or expression control segments), and the like. The delivered substances may be in the form of an aerosol, optionally produced within the inner catheter or prior to introduction to the inner catheter. Still further optionally, the substance may comprise a liquid which is instilled through the inner catheter. For both substance delivery and lavage, it will frequently be preferred to position the isolation catheter and inner catheter through a visualizing endotracheal or tracheostomy tube which has been previously placed in the patient's trachea. Suitable visualizing endotracheal tubes are described, for example, in U.S. Pat. No. 5,285,778, the full disclosure of which is incorporated herein by reference. Usually, a visualizing endotracheal or tracheostomy tube will include an inflatable cuff or other occlusion element so that the whole lungs may be isolated from the upper regions of the trachea. In this way, the patient may be ventilated through the tracheal tube while other regions of the lung are isolated. Moreover, direct visualization at the bifurcation between the left and right lungs helps position in place the isolation catheter to the target region to be isolated. Additionally, the regions of the lung above or proximal to the occlusion element on the isolation catheter may be ventilated and maintained at a different pressure through the tracheal tube. Thus, by employing isolation cuffs on the tracheal tube, the isolation catheter, and the inner catheter, at least three isolated zones within the lung may be maintained with different pressures being simultaneously maintained. Moreover, different substances can be delivered to each of these regions through the lumens of the inner catheter, isolation catheter, and the tracheal tube, respectively. Often, pressure within the isolated region may be maintained higher than that within the proximal regions of the lung (where pressure is being controlled through the tracheal tube) resulting in expansion of the isolated region which may be beneficial for a variety of reasons. Alternatively, pressure within the isolated region may be maintained below that of the proximal portions of the lung, reducing the risk of release of materials from the isolated region into the proximal portions of the lung. Moreover, when the inner catheter has an isolation cuff, a third distal region of the lung may be pressurized separately from the intermediate and proximal regions.
  • [0021]
    Introduction of the isolation catheter and/or inner catheter will preferably be performed over a guidewire. The guidewire will first be introduced to a point beyond the location in a bronchial passage where it is desired to position a distal end of the isolation catheter and/or inner catheter. Preferably the isolation catheter will comprise optical and illumination fibers which permit direct visual observation of the guidewire as the guidewire and isolation catheter are advanced. In particular, the guidewire and isolation catheter can be advanced in tandem so that, as successive bifurcations are approached, the physician can steer a curved end of the guidewire into the desired branch bronchial passage. After positioning the isolation catheter at its desired final location, an occlusion cuff may be expanded and the inner catheter optionally introduced over the guidewire or introduced directly through the main lumen of the isolation catheter without a guidewire. While the inner catheter may in some instances incorporate optical and illumination fibers, it will usually not have such imaging capabilities. Thus, positioning of the inner catheter will frequently be done solely by observation from the isolation catheter and/or under fluoroscopic or other external imaging. Of course, positioning of an isolation catheter can also be performed solely under fluoroscopic imaging (or in combination with both direct visual and fluoroscopic imaging), particularly when the isolation catheter does not include imaging capability.
  • [0022]
    In a further specific aspect of the methods of the present invention, the inner catheter may be moved and repositioned within the bronchial passages of the isolated region to deliver a substance or release a washing fluid for lavage at different points within the region. Optionally, the inner catheter can be moved (i.e., advanced distally or drawn proximally) while the substance or washing liquid is being released in order to better distribute the material within the isolated region. Further optionally, the inner catheter could also be moved through the isolated region in order to aspirate materials which have been introduced, either alone or in combination with aspiration through the main lumen of the isolation catheter.
  • [0023]
    Kits according to the present invention include at least an isolation catheter, and optionally include an inner catheter, a tracheal tube, and/or a guidewire. Other components including medical and bioactive reagents, e.g., drugs, washing liquids, or the like, may also be provided within the kits. In addition to the isolation catheter and optional other system components, the kits will comprise instructions for use setting forth a method of the present invention as generally set forth above. The kits will usually be packaged together in conventional medical packaging, such as a pouch, tray, tube, box, bag, or the like. Instructions for use may be provided on a separate printed sheet, or may printed in whole or in part on the packaging materials. When printed separately, the instructions are commonly referred to as a package insert. Usually, at least the isolation catheter and other components of the kit which would be used in the procedure will be packaged in a sterile manner within the kit.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0024]
    [0024]FIG. 1 is a side view of a sub-lobar isolation catheter constructed in accordance with the principles of the present invention.
  • [0025]
    [0025]FIG. 1A is a cross-sectional view taken along line 1A-1A in FIG. 1.
  • [0026]
    [0026]FIG. 1B is an alternative cross-sectional view similar to that shown in FIG. 1A.
  • [0027]
    [0027]FIG. 2 is a side view of a first alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
  • [0028]
    [0028]FIG. 2A is a cross-sectional view taken along line 2A-2A of FIG. 2.
  • [0029]
    [0029]FIG. 3 is a side view of a second alternative construction of a sub-lobar catheter constructed in accordance with the principles of the present invention.
  • [0030]
    [0030]FIG. 3A is a cross-sectional view taken along line 3A-3A of FIG. 3.
  • [0031]
    [0031]FIG. 4 illustrates a system comprising a sub-lobar isolation catheter and an inner catheter constructed in accordance with the principles of the present invention.
  • [0032]
    [0032]FIG. 5 is a side view of the inner catheter of FIG. 4 mounted within the sub-lobar isolation catheter, with portions broken away.
  • [0033]
    [0033]FIG. 6 illustrates a first alternative construction of the inner catheter of the present invention.
  • [0034]
    [0034]FIG. 6A is a cross-sectional view taken along line 6A-6A of FIG. 6.
  • [0035]
    [0035]FIG. 7 is a second alternative construction of the inner catheter of the present invention.
  • [0036]
    [0036]FIG. 7A is a cross-sectional view taken along line 7A-7A of FIG. 7.
  • [0037]
    [0037]FIG. 8 is a third alternative construction of the inner catheter of the present invention.
  • [0038]
    [0038]FIG. 8A is a cross-sectional view taken along line 8A-8A of FIG. 8.
  • [0039]
    [0039]FIG. 8B is a detailed view of the distal end of the catheter of FIG. 8 taken along line 8B-8B of FIG. 8.
  • [0040]
    [0040]FIG. 9 is a fourth alternative construction of the inner catheter of the present invention.
  • [0041]
    [0041]FIG. 9A is a cross-sectional view taken along line 9A-9A of FIG. 9.
  • [0042]
    [0042]FIG. 10 illustrates introduction of a sub-lobar isolation catheter to a diseased region within a lung according to the method of the present invention.
  • [0043]
    [0043]FIG. 11 is a detailed view of the introduction of FIG. 10 shown with the isolation catheter being passed through a visualizing endotracheal tube.
  • [0044]
    FIGS. 12A-12C illustrate use of the various inner catheters for performing particular procedures in accordance with the principles of the present invention.
  • [0045]
    [0045]FIG. 13 illustrates a kit constructed in accordance with the principles of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0046]
    Isolation of a lobar or sub-lobar region of the lung is accomplished by occluding a lumen of a bronchial passage (bronchiole) at a location distal to a first branch in the network of bronchial passages within the right or left lung. Substances may be delivered to and/or a washing fluid may be used to lavage the isolated lobar or sub-lobar region of the lung by introducing or exchanging materials through a lumen of an isolation catheter, usually in combination with delivery or exchange through a lumen of an associated inner catheter. An inflatable cuff or other expansible isolation element on the isolation catheter is positioned at an isolation location within the bronchial passage, and the cuff inflated. The inner catheter is then positioned at a desired location distal to the end of the isolation catheter, and the isolated region is thus accessible through at least two access lumens, i.e., one lumen through the inner catheter and a second annular lumen between the exterior of the inner catheter and the interior luminal wall of the isolation catheter. These access lumens may be used separately or in combination in a variety of ways to perform the methods of the present invention. The apparatus and methods of the present invention will now be described in greater detail.
  • [0047]
    Referring to FIGS. 1 and 1A, an isolation catheter 10 comprises a catheter body 12 having a proximal end 16 and a distal end 14. An inflatable isolation cuff 18 is disposed near the distal end 14 of the catheter body 12, and an inflation lumen 20 extends through the catheter body from a proximal port 22 on proximal hub 24 to the balloon 18. The catheter 10 further comprises an optical fiber or bundle 24 and an illumination fiber or bundle 26, both of which are brought out to a suitable connector 28 through a connecting cable 30. The optical fiber 24 and illuminating fiber 26 may be plugged into a variety of conventional imaging consoles which can provide a real time, visual image looking forwardly from the distal end 14 of the catheter body 12. Suitable commercial imaging consoles are available from suppliers, such as Pulmonx, Palo Alto, Calif., assignee of the present application as well as Olympus, Pentax and Stryker. The catheter body 12 further includes a main lumen 32 which extends the entire length of the catheter body and passes through connector hub 36 to proximal connector 34. As will be discussed in more detail below, the main lumen 32 can be used for introducing and/or aspirating materials which are introduced to or withdrawn from an isolated lobar or sub-lobar region of the lung. Most usually, the main lumen 32 will receive an inner catheter (FIGS. 4 and 5 below), and the isolation catheter and inner catheter will be utilized together for delivering, collecting, and removing materials from an isolated sub-lobar region of the lung.
  • [0048]
    As shown in FIGS. 1 and 1A, the catheter body 12 of the isolation catheter 10 is a single extrusion having four lumens or passages formed therein. Two of the lumens form the inflation lumen 20 and the main lumen 32, while the other two lumens house the optical fiber bundle 24 and the illumination fiber bundle 26. The catheter body 12 could also be formed from a plurality of separate tubular members which are held together by an outer cover, as illustrated in FIG. 11B. For example, an inner tube 40 can be disposed in parallel with the optical fiber bundle 24 and the illuminating fiber bundle 26. A separate tubular member 42 can also be placed co-axially on the exterior of tube 40, and all of the components held together by a cover 44 which may, for example, be shrink-wrapped over the assembly. An inflation lumen 46 is then provided in the space under the cover 44 which is unoccupied by the optical and tubular components. A variety of other specific construction designs may also be provided.
  • [0049]
    The catheter body 12 may be formed from conventional materials, such as polyamides (nylons), polyethylenes, polyurethanes, polytetrafluoroethylenes (PTFEs), polyimides, and the like. The inflatable cuff can be formed from other conventional materials, such as polyvinylchloride, polyurethanes, high density polyethylenes, low density polyethylenes, nylons, PTFEs, and the like. Exemplary and preferred dimensions for the catheter body 12 of the isolation catheter 10 have been set forth above.
  • [0050]
    A second exemplary isolation catheter 50 constructed in accordance with the principles of the present invention is illustrated in FIGS. 2 and 2A. The construction of isolation catheter 50 is generally the same as that for isolation catheter 10, and like components will be given like numbers. The principal difference between the catheters 50 and 10 is that catheter 50 includes a lens washing lumen 52 which extends from lens washing port 54 in the hub 56 to a position at the distal tip of the catheter body which lies immediately over a lens (not shown) formed at the distal end of the optical fiber or bundle 26. Because of the humid and contaminating nature of the lungs, it will be a significant benefit to be able to wash the optical viewing lens whenever the lens becomes obscured to do condensation or fouling.
  • [0051]
    A third exemplary construction of the isolation catheter of the present invention is illustrated in FIGS. 3 and 3A. There, an isolation catheter 60 comprises generally the same components as catheters 10 and 50, except that catheter body 12 further includes a lumen 62 which receives a guidewire (or alternatively an articulating steering mechanism) and which extends from port 64 on hub 66 to the distal end 14 of the catheter body 12. Thus, isolation catheter 60 is specially adapted for introduction over a guidewire (or other steering mechanism) according to the methods of the present invention and as described in more detail below. It will be appreciated, of course, that the earlier embodiments could also be introduced over a guidewire where the guidewire is passed through the main lumen 32, but in such cases the main lumen would have to be emptied i.e., the inner catheter (if used) would have to be removed from the isolation catheter. Optionally, the isolation catheter 60 can also include a vibratory element 66 near its distal end. The vibratory element could be a mechanically driven surface, but will usually comprise an ultrasonic transducer intended to deliver vibratory energy to disrupt blockages in the bronchus, enhance drug delivery, or the like.
  • [0052]
    Systems 70 according to the present invention comprise an isolation catheter 10 (or any of the other isolation catheters described above or which would come within the principles of the present invention) and an inner catheter 80. As illustrated in FIGS. 4 and 5, the inner catheter 80 is sized and adapted to fit within the main lumen 32 of the isolation catheter 10. The inner catheter 80 has a distal end 82 and a proximal end 84 which terminates in a connecting hub 86. The isolation catheter 10 includes a hub 96 which is similar to the previously described hubs, except that a proximal end has been modified to slidably receive the inner catheter 80. As shown, an O-ring 90 is provided to provide a sliding pneumatic or hydraulic seal about the inner catheter. Additionally, an access port 92 is provided in the hub 96 to permit communication with the annular lumen 94 disposed between the exterior of inner catheter 80 and the interior of the main lumen 32 of the isolation catheter 10. In this way, materials can be withdrawn or introduced through the isolation catheter 10 as well as through the lumen of the inner catheter 80. More particularly, it permits two spaced-apart access points, i.e., at the distal ends of the isolation catheter 10 and inner catheter 80, respectively, to be established within an isolated lobar or sub-lobar region of the lungs. Using two access points, a variety of substance delivery and lavage protocols can be run, as described in more detail below.
  • [0053]
    A first alternative embodiment of an inner catheter 100 is illustrated in FIGS. 6 and 6A. Inner catheter 100 includes catheter body 102 having an inflatable isolation cuff 104 near its distal end. A plurality of infusion/aspiration ports 106 are also formed near the distal end 103 of the catheter body 102 and are connected by a lumen 108 to an aspiration/infusion port 110 in proximal hub 112. The inflatable cuff 104 may be inflated by connecting a suitable inflation source to connector 114 which delivers the inflation medium through lumen 116 to the cuff 104. A central lumen 120 extends the length of the catheter body from its distal end 103 to a connection port 122 in the hub 112. By providing the infusion/aspiration ports 106 proximal to the inflatable cuff 104, it will be appreciated that substances may be delivered or removed from a region which is proximal to the cuff 104 but distal to the isolation cuff on the isolation catheter with which the inner catheter 100 is used.
  • [0054]
    Yet a further alternative embodiment of an inner catheter 130 is illustrated in FIGS. 7 and 7A. The inner catheter 130 includes an ultrasonic or other vibratory element 132 (shown in broken line) at or near its distal end 134. The ultrasonic element 132 may be positioned at the distal end of a lumen 136 which extends through the length of the catheter 130. The lumen 136 may thus hold wires necessary to power the ultrasonic transducer, where the wires are brought out through a connecting cable 140 and terminate in a plug 142. An aspiration/infusion lumen 150 also extends the length of the catheter 130 and terminates in a luer or other connector 152 at the proximal end of the catheter. Optionally, a similar ultrasonic or other vibratory element may be disposed on the isolation catheter, either in addition to or in place of the vibration element 132 on the inner catheter. Although shown proximal to cuff 18, the vibratory element 66 may also be placed distal to the cuff to deliver energy into an isolated region.
  • [0055]
    Referring now to FIGS. 8, 8A, and 8B, still a further embodiment of an inner catheter 160 will be described. The catheter 160 comprises a catheter body 162 having a distal end 164 and a proximal end 166. A pair of lumens 168 and 170 extend the length of the catheter body 162 from ports 172 and 174, respectively, and proximal hub of 176 to each of the lumens 168 and 170 is suitable for delivering a material, either liquid, aerosol, or solid (in some flowable form), from the ports 172 and 174 to a mixing region 180 near a distal instillation port 182 at a distal tip of the catheter. For example, air or other gas may be delivered through the larger lumen 170 so that it flows the mixing area 180. By delivering a liquid or powder through the smaller lumen 168, the airflow can act as a Venturi in suspending an aerosolizing material which is delivered to the mixing area. In this way, droplets or particulates can be delivered or instilled directly within an isolated lobar or sub-lobar region of the lung. By properly controlling the particulate or droplet size, i.e., to arrange generally between 0.1 μm to 5 μm, absorption of these materials into the alveolar regions of the lungs can be enhanced. By controlling the particulate or droplet size outside this range, usually above 5 μm, preferably above 10 μm, local delivery (i.e., not systemically absorbed) of a drug or other substance can be achieved.
  • [0056]
    Referring now to FIGS. 9 and 9A, still yet a further embodiment of an inner catheter 200 constructed in accordance with the principles of the present invention will be described. The inner catheter 200 comprises a catheter body 202 having a distal end 204 and a proximal end 206. The catheter body includes a central lumen 210 and a pair of instillation lumens 212 and 214. The catheter would be suitable for aerosolization of substances, particularly by delivering a liquid or solid powder substance through one of the lumens 212 and air or other aerosolization gas through the other lumen 214. The central lumen 210 could be used for aspiration, delivery of other drug materials, or the like.
  • [0057]
    Referring now to FIGS. 10, 11, and 12A-12C, methods according to the present invention will be described. Most generally, an isolation catheter 10 may be introduced through the mouth, the trachea T and into a lobe L of the lung until it reaches a diseased region DR. Alternatively, the isolation catheter 10 could be introduced through an incision in the neck, usually through a tracheostomy tube. At that point, cuff 18 may be inflated to isolate regions of the lung distal to the inflated cuff in the bronchial passage. As illustrated in FIG. 11, catheter 10 may optionally be delivered through a visualizing endotracheal tube VETT (or visualizing tracheostomy tube), where a cuff C on the tube is inflated within the trachea T at a region just above the main lung bifurcation into the right and left lungs RL and LL. Further optionally, the isolation catheter 10 may be advanced over a guidewire GW, where visualization of the guidewire immediately ahead of the catheter may be observed on the video screen V attached to the optical and illumination fibers within the catheter 10. In particular, the guidewire may be advanced just ahead of the distal end of the catheter 10 in tandem so that the guidewire can be observed as it is rotated and introduced selectively into the bronchial passages at bifurcations. Alternatively, or additionally, advancement of the catheter 10 may be observed fluoroscopically or using any other available external imaging systems.
  • [0058]
    Once the catheter 10 is in place beyond a second bifurcation SB in the bronchial passages, as illustrated in FIG. 12A, the inflatable cuff 18 may be inflated to both anchor the distal end of the catheter and isolate regions of the lung distal thereto. After the cuff 18 is inflated, the inner catheter 80 may be advanced through the main lumen 34 so that the distal end 82 of the inner catheter progresses distally into a desired bronchial passage. Advancement of the distal end 82 may optionally be over a guidewire and will usually be performed under visual imaging using the optical illuminating fibers in the isolation catheter 10. Once the inner catheter has been properly positioned, as shown in FIG. 12B, a desired procedure can be performed. For example, a drug can be delivered through the distal end 82 of the inner catheter to treat a target region TR, shown in broken line in FIG. 12B, additionally or alternatively, the target region TR can be lavaged by introducing a washing fluid through either catheter 10 or 80 and/or collecting the fluid through either of catheter 10 or 80.
  • [0059]
    Alternatively, as shown in FIG. 12C, inner catheter 100 having inflatable cuff 104 at its distal end may be introduced through the isolation catheter 10. By then inflating cuff 104 distally relative to cuff 18 on isolation catheter 10, a modified target region MTR can be defined. In particular, the target region MTR in FIG. 12C will be more limited in volume than that formed in FIG. 12B where there is no distal isolation. Use of the second isolation cuff 104 on the inner catheter 100 permits much more specifically focused treatment protocols, both drug delivery and lavage, to be performed. By delivering or aspirating the materials through the ports 106, it will be appreciated that the treatment is substantially limited to between the two cuffs 18 and 104.
  • [0060]
    Referring now to FIG. 13, a kit 300 according to the present invention will comprise at least a lobar or sub-lobar isolation catheter 10 and an inner catheter 80 together with instructions for use IFU. Optionally, the kits may further include other system components as described above, such as a visualizing endotracheal tube VET, a guidewire GW, and/or various reagents (not shown). The instructions for use IFU will set forth any of the methods as described above, and all kit components will usually be packaged together in a suitable package 350, such as a pouch, tray, tube, box, bag, or the like. Usually, those kits components, such as the isolation catheter 10 and inner catheter 80, which will be used in performing the procedure on the patient, will be sterilized and maintained sterilely within the kit. Optionally, separate pouches, bags, trays, or other packaging materials may be provided within a larger package, where the smaller packs may be separately opened and will separately maintain the components in a sterile fashion.
  • [0061]
    While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US66792644 Mar 200020 Jan 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US66949792 Mar 200124 Feb 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US672236014 Jun 200120 Apr 2004Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US699718928 Jul 200314 Feb 2006Broncus Technologies, Inc.Method for lung volume reduction
US701389913 Aug 200421 Mar 2006Engineered Medical System, Inc.Perilaryngeal oral airway with multi-lumen esophogeal-obturator
US70863983 Jul 20038 Aug 2006Cordis CorporationLong term oxygen therapy system
US733458119 Apr 200426 Feb 2008Ventus Medical, Inc.Methods and devices for improving breathing in patients with pulmonary disease
US7585276 *1 Mar 20058 Sep 2009Fujinon CorporationEndoscope system and operation method for endoscope
US761500313 May 200510 Nov 2009Ethicon Endo-Surgery, Inc.Track for medical devices
US761500516 May 200310 Nov 2009Ethicon Endo-Surgery, Inc.Medical apparatus for use with an endoscope
US764845713 May 200519 Jan 2010Ethicon Endo-Surgery, Inc.Method of positioning a device on an endoscope
US766218130 Mar 200616 Feb 2010Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US767028214 Jun 20052 Mar 2010Pneumrx, Inc.Lung access device
US76703733 Mar 19982 Mar 2010Pulmonx CorporationOcclusion device
US768233230 Jun 200423 Mar 2010Portaero, Inc.Methods to accelerate wound healing in thoracic anastomosis applications
US768601312 Feb 200830 Mar 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US769115124 Oct 20066 Apr 2010Spiration, Inc.Articulable Anchor
US771711525 Nov 200318 May 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US772630512 Feb 20081 Jun 2010Portaero, Inc.Variable resistance pulmonary ventilation bypass valve
US77354918 Dec 200515 Jun 2010Ventus Medical, Inc.Methods of treating respiratory disorders
US77354928 Dec 200515 Jun 2010Ventus Medical, Inc.Nasal respiratory devices
US77530526 Feb 200813 Jul 2010Portaero, Inc.Intra-thoracic collateral ventilation bypass system
US775769222 Apr 200920 Jul 2010Spiration, Inc.Removable lung reduction devices, systems, and methods
US77668918 Jul 20053 Aug 2010Pneumrx, Inc.Lung device with sealing features
US77669388 Jul 20053 Aug 2010Pneumrx, Inc.Pleural effusion treatment device, method and material
US777147218 Nov 200510 Aug 2010Pulmonx CorporationBronchial flow control devices and methods of use
US777596814 Jun 200517 Aug 2010Pneumrx, Inc.Guided access to lung tissues
US778908331 Jan 20087 Sep 2010Portaero, Inc.Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease
US779814725 Jul 200321 Sep 2010Pulmonx CorporationBronchial flow control devices with membrane seal
US77981488 Dec 200521 Sep 2010Ventus Medical, Inc.Respiratory devices
US78061207 Jun 20075 Oct 2010Ventus Medical, Inc.Nasal respiratory devices for positive end-expiratory pressure
US781127427 Apr 200412 Oct 2010Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US781491229 Jun 200519 Oct 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US782436610 Dec 20042 Nov 2010Portaero, Inc.Collateral ventilation device with chest tube/evacuation features and method
US78287897 Apr 20089 Nov 2010Portaero, Inc.Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis
US784206123 Dec 200330 Nov 2010Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US785422828 Mar 200521 Dec 2010Pulmonx CorporationBronchial flow control devices and methods of use
US785697922 May 200728 Dec 2010Ventus Medical, Inc.Nasal respiratory devices
US7857754 *13 May 200528 Dec 2010Ethicon Endo-Surgery, Inc.Apparatus useful for positioning a device on an endoscope
US78750483 Sep 200425 Jan 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US78875854 Mar 200915 Feb 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US78960086 Aug 20071 Mar 2011Portaero, Inc.Lung reduction system
US789688710 Apr 20071 Mar 2011Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US790583013 May 200515 Mar 2011Ethicon Endo-Surgery, Inc.Sheath for use with an endoscope
US790980318 Feb 200922 Mar 2011Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US792732418 Feb 200919 Apr 2011Portaero, Inc.Aspirator and method for pneumostoma management
US793164121 Feb 200826 Apr 2011Portaero, Inc.Visceral pleura ring connector
US794293115 Aug 200517 May 2011Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US798785211 Feb 20092 Aug 2011Ventus Medical, Inc.Nasal devices
US799256314 Jan 20089 Aug 2011Ventus Medical, Inc.Methods and devices for improving breathing in patients with pulmonary disease
US799256424 Feb 20109 Aug 2011Ventus Medical, Inc.Respiratory devices
US80207005 Dec 200820 Sep 2011Ventus Medical, Inc.Packaging and dispensing nasal devices
US802132018 Feb 200920 Sep 2011Portaero, Inc.Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma
US802138519 Jul 200720 Sep 2011Spiration, Inc.Removable anchored lung volume reduction devices and methods
US80294927 Apr 20084 Oct 2011Portaero, Inc.Method for treating chronic obstructive pulmonary disease
US804330110 Apr 200925 Oct 2011Spiration, Inc.Valve loader method, system, and apparatus
US806135718 Jun 200822 Nov 2011Ventus Medical, Inc.Adhesive nasal respiratory devices
US8062315 *12 Feb 200822 Nov 2011Portaero, Inc.Variable parietal/visceral pleural coupling
US807936810 Mar 201020 Dec 2011Spiration, Inc.Bronchoscopic lung volume reduction method
US8104474 *23 Aug 200531 Jan 2012Portaero, Inc.Collateral ventilation bypass system with retention features
US813623010 Oct 200820 Mar 2012Spiration, Inc.Valve loader method, system, and apparatus
US813652014 Jan 201020 Mar 2012Pulmonx CorporationOcclusion device
US814245512 Sep 200827 Mar 2012Pneumrx, Inc.Delivery of minimally invasive lung volume reduction devices
US815782312 Sep 200817 Apr 2012Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US81578372 Jun 200617 Apr 2012Pneumrx, Inc.Minimally invasive lung volume reduction device and method
US816303421 Feb 200824 Apr 2012Portaero, Inc.Methods and devices to create a chemically and/or mechanically localized pleurodesis
US81778054 Aug 201115 May 2012Spiration, Inc.Removable anchored lung volume reduction devices and methods
US820668425 Feb 200526 Jun 2012Pulmonx CorporationMethods and devices for blocking flow through collateral pathways in the lung
US821530816 Sep 201010 Jul 2012Ventus Medical, Inc.Sealing nasal devices for use while sleeping
US822046019 Nov 200417 Jul 2012Portaero, Inc.Evacuation device and method for creating a localized pleurodesis
US823158125 Jan 201131 Jul 2012Portaero, Inc.Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease
US823504616 Sep 20107 Aug 2012Ventus Medical, Inc.Nasal devices for use while sleeping
US824030916 Nov 200714 Aug 2012Ventus Medical, Inc.Adjustable nasal devices
US825106716 Aug 201028 Aug 2012Pulmonx CorporationBronchial flow control devices with membrane seal
US825200318 Feb 200928 Aug 2012Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US825738115 Dec 20104 Sep 2012Spiration, Inc.One-way valve devices for anchored implantation in a lung
US828155718 Aug 20119 Oct 2012Ventus Medical, Inc.Method of packaging and dispensing nasal devices
US82826602 Jul 20089 Oct 2012Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US829190917 Sep 201023 Oct 2012Ventus Medical, Inc.Methods of treating a disorder by inhibiting expiration
US830260617 Sep 20106 Nov 2012Ventus Medical, Inc.Methods of treating a sleeping subject
US830260717 Nov 20116 Nov 2012Ventus Medical, Inc.Adhesive nasal respiratory devices
US832323020 Jan 20104 Dec 2012Portaero, Inc.Methods and devices to accelerate wound healing in thoracic anastomosis applications
US833654012 Feb 200925 Dec 2012Portaero, Inc.Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
US834788018 Feb 20098 Jan 2013Potaero, Inc.Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease
US83478818 Jan 20108 Jan 2013Portaero, Inc.Pneumostoma management device with integrated patency sensor and method
US834890618 Feb 20098 Jan 2013Portaero, Inc.Aspirator for pneumostoma management
US83571394 Nov 200822 Jan 2013Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US836572218 Feb 20095 Feb 2013Portaero, Inc.Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US836573616 Sep 20105 Feb 2013Ventus Medical, Inc.Nasal devices with respiratory gas source
US838868222 Jun 20105 Mar 2013Pulmonx CorporationBronchial flow control devices and methods of use
US84146551 Jul 20109 Apr 2013Spiration, Inc.Removable lung reduction devices, systems, and methods
US843009418 Feb 200930 Apr 2013Portaero, Inc.Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US844469012 Jan 201121 May 2013Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US845363718 Feb 20094 Jun 2013Portaero, Inc.Pneumostoma management system for treatment of chronic obstructive pulmonary disease
US845363818 Feb 20094 Jun 2013Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US84547085 Apr 20104 Jun 2013Spiration, Inc.Articulable anchor
US846470818 Feb 200918 Jun 2013Portaero, Inc.Pneumostoma management system having a cosmetic and/or protective cover
US847444918 Feb 20092 Jul 2013Portaero, Inc.Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease
US847446017 Sep 20102 Jul 2013Pulmonx CorporationImplanted bronchial isolation devices and methods
US84753898 Jun 20102 Jul 2013Portaero, Inc.Methods and devices for assessment of pneumostoma function
US849160218 Feb 200923 Jul 2013Portaero, Inc.Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US85065776 Jul 201213 Aug 2013Portaero, Inc.Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease
US851805311 Feb 201027 Aug 2013Portaero, Inc.Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US863260511 Sep 200921 Jan 2014Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US864739226 Apr 201211 Feb 2014Spiration, Inc.Articulable anchor
US86679731 Nov 201111 Mar 2014Spiration, Inc.Bronchoscopic lung volume reduction method
US866870714 Sep 201211 Mar 2014Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US870262629 Dec 200622 Apr 2014Acclarent, Inc.Guidewires for performing image guided procedures
US870795520 Jun 201129 Apr 2014Theravent, Inc.Methods and devices for improving breathing in patients with pulmonary disease
US871516930 Oct 20076 May 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US872159123 Jan 201213 May 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US872173418 May 201013 May 2014Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction device
US874092114 Sep 20123 Jun 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US874738924 Apr 200710 Jun 2014Acclarent, Inc.Systems for treating disorders of the ear, nose and throat
US8764632 *25 Mar 20111 Jul 2014Eric James KezirianEndoscopic device and system
US876470930 Jun 20101 Jul 2014Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US876472618 Aug 20091 Jul 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US876472922 Dec 20081 Jul 2014Acclarent, Inc.Frontal sinus spacer
US877792615 Mar 201315 Jul 2014Acclarent, Inc.Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasel or paranasal structures
US879524113 May 20115 Aug 2014Spiration, Inc.Deployment catheter
US882804118 Mar 20109 Sep 2014Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US88521437 Apr 20107 Oct 2014Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US885858618 Jan 200714 Oct 2014Acclarent, Inc.Methods for enlarging ostia of paranasal sinuses
US88647879 Apr 200821 Oct 2014Acclarent, Inc.Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
US887089329 Apr 201028 Oct 2014Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US887571127 May 20114 Nov 2014Theravent, Inc.Layered nasal respiratory devices
US887679115 Sep 20104 Nov 2014Pulmonx CorporationCollateral pathway treatment using agent entrained by aspiration flow current
US888880013 Mar 201218 Nov 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US889461416 Feb 200625 Nov 2014Acclarent, Inc.Devices, systems and methods useable for treating frontal sinusitis
US890592226 Mar 20129 Dec 2014Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat
US892664729 Mar 20136 Jan 2015Spiration, Inc.Removable anchored lung volume reduction devices and methods
US893227616 May 200713 Jan 2015Acclarent, Inc.Shapeable guide catheters and related methods
US893231014 Sep 201213 Jan 2015Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US895122518 May 200610 Feb 2015Acclarent, Inc.Catheters with non-removable guide members useable for treatment of sinusitis
US895631920 Jul 201217 Feb 2015Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8961398 *31 Oct 200724 Feb 2015Acclarent, Inc.Methods and apparatus for treating disorders of the ear, nose and throat
US896149529 Oct 200724 Feb 2015Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US89744846 Mar 201310 Mar 2015Spiration, Inc.Removable lung reduction devices, systems, and methods
US897452729 Mar 201310 Mar 2015Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US89851167 Jun 200724 Mar 2015Theravent, Inc.Layered nasal devices
US898633625 Jan 201124 Mar 2015Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US905596522 Mar 201016 Jun 2015Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US908925815 Mar 200728 Jul 2015Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US910138416 Jan 200911 Aug 2015Acclarent, Inc.Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US91075748 Dec 201118 Aug 2015Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US912563923 Nov 20058 Sep 2015Pneumrx, Inc.Steerable device for accessing a target site and methods
US915549224 Sep 201013 Oct 2015Acclarent, Inc.Sinus illumination lightwire device
US916796131 Oct 200727 Oct 2015Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US917366911 Sep 20093 Nov 2015Pneumrx, Inc.Enhanced efficacy lung volume reduction devices, methods, and systems
US91798235 Jun 200910 Nov 2015Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US919240319 Dec 201324 Nov 2015Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systems
US919866913 Dec 20131 Dec 2015Spiration, Inc.Articulable anchor
US921118124 Sep 201215 Dec 2015Pulmonx CorporationImplant loading device and system
US922087930 Apr 201429 Dec 2015Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US92381138 Sep 201019 Jan 2016Theravent, Inc.Nasal respiratory devices for positive end-expiratory pressure
US924183421 Mar 201426 Jan 2016Acclarent, Inc.Devices, systems and methods for treating disorders of the ear, nose and throat
US926540731 Jul 200723 Feb 2016Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US93083614 Mar 201312 Apr 2016Acclarent, Inc.Implantable devices and methods for treating sinusitis and other disorders
US93268736 Dec 20113 May 2016Spiration, Inc.Valve loader method, system, and apparatus
US935175016 Dec 200931 May 2016Acclarent, Inc.Devices and methods for treating maxillary sinus disease
US935815019 Mar 20127 Jun 2016Benechill, Inc.Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US93706495 Feb 201521 Jun 2016Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US93991211 Jul 200926 Jul 2016Acclarent, Inc.Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US940263224 Apr 20142 Aug 2016Pneumrx, Inc.Lung volume reduction devices, methods, and systems
US940263313 Mar 20142 Aug 2016Pneumrx, Inc.Torque alleviating intra-airway lung volume reduction compressive implant structures
US940297123 Jan 20142 Aug 2016Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US941389614 Mar 20139 Aug 2016The Spectranetics CorporationTissue slitting methods and systems
US946836219 Apr 201218 Oct 2016Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US947453326 Mar 201425 Oct 2016Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction device
US955469114 May 200731 Jan 2017Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US957248019 Jun 201421 Feb 2017Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US96035065 Jun 200928 Mar 2017Acclarent, Inc.Methods and devices for facilitating visualization in a surgical environment
US961042816 Oct 20144 Apr 2017Acclarent, Inc.Devices, systems and methods useable for treating frontal sinusitis
US96227526 Mar 201518 Apr 2017Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US964947730 Apr 201416 May 2017Acclarent, Inc.Frontal sinus spacer
US972412214 Mar 20138 Aug 2017The Spectranetics CorporationExpandable lead jacket
US973719511 Mar 201422 Aug 2017Sanovas, Inc.Handheld resector balloon system
US976369214 Mar 201319 Sep 2017The Spectranetics CorporationTissue slitting methods and systems
US97825586 Aug 201410 Oct 2017Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systems
US981437930 Oct 200714 Nov 2017Acclarent, Inc.Methods and apparatus for treating disorders of the ear nose and throat
US20020095209 *8 Feb 200218 Jul 2002Gholam-Reza Zadno-AziziBody fluid flow control device
US20020112729 *21 Feb 200122 Aug 2002Spiration, Inc.Intra-bronchial obstructing device that controls biological interaction with the patient
US20030070682 *10 Oct 200217 Apr 2003Wilson Peter M.Bronchial flow control devices and methods of use
US20030158515 *11 Dec 200221 Aug 2003Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US20030183235 *17 Apr 20032 Oct 2003Spiration, Inc.Bronchial obstruction device deployment system and method
US20030195385 *16 Apr 200216 Oct 2003Spiration, Inc.Removable anchored lung volume reduction devices and methods
US20030199972 *18 Apr 200323 Oct 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030212412 *9 May 200213 Nov 2003Spiration, Inc.Intra-bronchial obstructing device that permits mucus transport
US20030212452 *3 Jun 200313 Nov 2003Gholam-Reza Zadno-AziziBody fluid flow control device
US20030216769 *17 May 200220 Nov 2003Dillard David H.Removable anchored lung volume reduction devices and methods
US20030228344 *6 Mar 200311 Dec 2003Fields Antony J.Methods and devices for inducing collapse in lung regions fed by collateral pathways
US20040039250 *28 May 200326 Feb 2004David TholfsenGuidewire delivery of implantable bronchial isolation devices in accordance with lung treatment
US20040055606 *25 Jul 200325 Mar 2004Emphasys Medical, Inc.Bronchial flow control devices with membrane seal
US20040060563 *25 Jul 20031 Apr 2004Alan RapackiBronchial flow control devices and methods of use
US20040074491 *20 Aug 200322 Apr 2004Michael HendricksenDelivery methods and devices for implantable bronchial isolation devices
US20040078054 *28 Jul 200322 Apr 2004Broncus Technologies, Inc.Method for lung volume reduction
US20040134487 *6 Nov 200315 Jul 2004Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20040148035 *25 Nov 200329 Jul 2004Michael BarrettDelivery methods and devices for implantable bronchial isolation devices
US20040200484 *8 Apr 200314 Oct 2004Springmeyer Steven C.Bronchoscopic lung volume reduction method
US20040206349 *17 May 200421 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and methods
US20040210248 *12 Mar 200321 Oct 2004Spiration, Inc.Apparatus, method and assembly for delivery of intra-bronchial devices
US20040211412 *17 May 200428 Oct 2004Alferness Clifton A.Removable lung reduction devices, systems, and method
US20040243393 *29 May 20032 Dec 2004Microsoft CorporationSemantic object synchronous understanding implemented with speech application language tags
US20050033344 *3 Sep 200410 Feb 2005Dillard David H.One-way valve devices for anchored implantation in a lung
US20050051163 *6 Nov 200310 Mar 2005Deem Mark E.Methods and devices for use in performing pulmonary procedures
US20050061322 *3 Nov 200424 Mar 2005PulmonxMethod and arrangement for reducing the volume of a lung
US20050066974 *28 May 200331 Mar 2005Antony FieldsModification of lung region flow dynamics using flow control devices implanted in bronchial wall channels
US20050137714 *22 Dec 200323 Jun 2005Gonzalez Hugo X.Bronchoscopic repair of air leaks in a lung
US20050145253 *2 Mar 20057 Jul 2005Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20050166925 *28 Mar 20054 Aug 2005Emphasys Medical, Inc., A California CorporationBronchial flow control devices and methods of use
US20050178389 *26 Jan 200518 Aug 2005Shaw David P.Disease indications for selective endobronchial lung region isolation
US20050196344 *25 Feb 20058 Sep 2005Mccutcheon JohnMethods and devices for blocking flow through collateral pathways in the lung
US20050203400 *11 Feb 200515 Sep 2005Zappala Stephen M.System and method for precisely identifying a configuration of an anatomical space in real time
US20050222500 *1 Mar 20056 Oct 2005Fujinon CorporationEndoscope system and operation method for endoscope
US20060004305 *29 Jun 20055 Jan 2006George Robert MDelivery methods and devices for implantable bronchial isolation devices
US20060009748 *14 Jun 200512 Jan 2006Mathis Mark LMethod of compressing a portion of a lung
US20060020347 *8 Mar 200526 Jan 2006Michael BarrettImplanted bronchial isolation devices and methods
US20060030863 *20 Jul 20059 Feb 2006Fields Antony JImplanted bronchial isolation device delivery devices and methods
US20060032497 *11 Jul 200516 Feb 2006Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20060032505 *13 Aug 200416 Feb 2006Engineered Medical Systems, Inc.Perilaryngeal oral airway with multi-lumen esophogeal-obturator
US20060076023 *29 Nov 200513 Apr 2006Emphasys Medical, Inc., A Delaware CorporationBronchial flow control devices and methods of use
US20060144398 *8 Dec 20056 Jul 2006Rajiv DoshiRespiratory devices
US20060150978 *8 Dec 200513 Jul 2006Ventus Medical, Inc.Methods of treating respiratory disorders
US20060150979 *8 Dec 200513 Jul 2006Ventus Medical, Inc.Nasal respiratory devices
US20060174870 *30 Mar 200610 Aug 2006Deem Mark EMethods and devices for use in performing pulmonary procedures
US20060200076 *3 May 20067 Sep 2006Gonzalez Hugo XDevice and method for intra-bronchial provision of a therapeutic agent
US20060206147 *3 May 200614 Sep 2006Devore Lauri JIntra-bronchial obstruction device that provides a medicant intra-bronchially to the patient
US20060235432 *3 May 200619 Oct 2006Devore Lauri JIntra-bronchial obstructing device that controls biological interaction with the patient
US20060235467 *2 May 200619 Oct 2006Devore Lauri JRemovable anchored lung volume reduction device and methods
US20060249164 *3 May 20069 Nov 2006Springmeyer Steven CBronchoscopic lung volume reduction method
US20060258902 *13 May 200516 Nov 2006Spivey James TApparatus useful for positioning a device on an endoscope
US20060258903 *13 May 200516 Nov 2006David StefanchikMethod of inserting a feeding tube
US20060258904 *13 May 200516 Nov 2006David StefanchikFeeding tube and track
US20060258907 *13 May 200516 Nov 2006David StefanchikTrack for medical devices
US20060258910 *13 May 200516 Nov 2006David StefanchikMethod of positioning a device on an endoscope
US20060283462 *25 Aug 200621 Dec 2006Fields Antony JMethods and devices for inducing collapse in lung regions fed by collateral pathways
US20070005083 *1 Sep 20064 Jan 2007Sabaratham SabanathanOcclusion device
US20070063687 *20 Sep 200522 Mar 2007Dacheng ZhouCircuit and method for bias voltage generation
US20070185531 *10 Apr 20079 Aug 2007Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US20070232992 *24 Oct 20064 Oct 2007James KutskoArticulable anchor
US20070235846 *1 Apr 200611 Oct 2007Stats Chippac Ltd.Integrated circuit package system with net spacer
US20070293727 *31 Jul 200720 Dec 2007Acclarent, Inc.Endoscopic methods and devices for transnasal procedures
US20080041373 *7 Jun 200721 Feb 2008Ventus Medical, Inc.Nasal devices
US20080119693 *31 Oct 200722 May 2008Acclarent, Inc.Methods and Apparatus for Treating Disorders of the Ear, Nose and Throat
US20080125626 *30 Oct 200729 May 2008Acclarent, Inc.Devices, Systems and Methods Useable for Treating Sinusitis
US20080132938 *29 Oct 20075 Jun 2008Acclarent, Inc.Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat
US20080173309 *14 Jan 200824 Jul 2008Rajiv DoshiMethods and devices for improving breathing in patients with pulmonary disease
US20080178874 *16 Nov 200731 Jul 2008Ventus Medical, Inc.Adjustable nasal devices
US20080249503 *4 Jun 20089 Oct 2008Fields Antony JMethods and devices for lung treatment
US20080287878 *21 Feb 200820 Nov 2008Portaero, Inc.Pulmonary visceral pleura anastomosis reinforcement
US20080287908 *9 Apr 200820 Nov 2008Acclarent, Inc.Ethmoidotomy System and Implantable Spacer Devices Having Therapeutic Substance Delivery Capability for Treatment of Paranasal Sinusitis
US20090050144 *18 Jun 200826 Feb 2009Ryan Kendall PierceAdhesive nasal respiratory devices
US20090182369 *4 Mar 200916 Jul 2009Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20090205651 *18 Feb 200920 Aug 2009Portaero, Inc.One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease
US20090255537 *24 Jun 200915 Oct 2009PulmonxDisease indications for selective endobronchial lung region isolation
US20090287051 *22 Jul 200919 Nov 2009Fujinon CorporationEndoscope system and operation method for endoscope
US20090301480 *9 Jun 200810 Dec 2009Mamdouh ElsakkaDiagnostic sample collection system and method of use
US20090306544 *9 Jun 200810 Dec 2009Ho-Kin NgInstillation/aspiration device
US20090306545 *9 Jun 200810 Dec 2009Mamdouh ElsakkaBronchoalveolar lavage catheter assembly
US20090318757 *23 Jun 200824 Dec 2009Percuvision, LlcFlexible visually directed medical intubation instrument and method
US20100042046 *18 Aug 200918 Feb 2010Acclarent, Inc.Devices, systems and methods useable for treating sinusitis
US20100147308 *24 Feb 201017 Jun 2010Rajiv DoshiRespiratory devices
US20110017207 *16 Aug 201027 Jan 2011Pulmonx CorporationBronchial flow control devices with membrane seal
US20110060214 *18 Nov 201010 Mar 2011Acclarent, Inc.Systems and Methods for Performing Image Guided Procedures Within the Ear, Nose, Throat and Paranasal Sinuses
US20110112512 *16 Dec 200912 May 2011Acclarent, Inc.Devices and methods for treating maxillary sinus disease
US20110208228 *12 Jan 201125 Aug 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US20110226238 *17 Sep 201022 Sep 2011Pulmonx CorporationImplanted bronchial isolation devices and methods
US20110251457 *25 Mar 201113 Oct 2011Eric James KezirianEndoscopic device and system
US20140081252 *14 Mar 201320 Mar 2014The Spectranetics CorporationTissue slitting methods and systems
US20140275777 *15 Mar 201318 Sep 2014Erhan H. GundayResector Balloon Catheter With Multi-Port Hub
US20140350335 *2 Jun 201427 Nov 2014Eric James KezirianEndoscopic device and system
CN105536081A *22 Jan 20164 May 2016长江大学Full-automatic body cavity effusion and pneumatosis extraction instrument
EP1386635A1 *29 Jul 20034 Feb 2004Cordis CorporationLong term oxygen therapy system
EP1669095A12 Dec 200514 Jun 2006Nitinol Development CorporationCollateral ventilation device with chest tube/evacuation features
EP1757322A1 *21 Aug 200628 Feb 2007Nitinol Development CorporationCollateral ventilation bypass system with retention features
EP1888156A2 *11 May 200620 Feb 2008Benechill, Inc.Methods and devices for non-invasive cerebral and systemic cooling
EP1888156A4 *11 May 20069 Apr 2014Benechill IncMethods and devices for non-invasive cerebral and systemic cooling
WO2004064885A3 *7 Jan 200421 Oct 2004PulmonxMethods and arrangement for reducing the volume of the lung
WO2009152107A1 *8 Jun 200917 Dec 2009Allegiance CorporationBronchoalveolar lavage catheter assembly
Classifications
U.S. Classification604/96.01, 600/116
International ClassificationA61M16/04, A61M1/00, A61M25/00, A61M25/06
Cooperative ClassificationA61M2205/587, A61M16/0486, A61M2025/1052, A61M16/0463, A61M2025/0036, A61M25/0662, A61M25/003, A61M25/0032, A61M2210/1039, A61M1/0084, A61M2025/0034, A61M1/0058, A61M16/0459, A61M16/0404
European ClassificationA61M25/00R1M6, A61M16/04D, A61M1/00T2, A61M1/00K, A61M25/06H